Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Castrioto

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
NPJ Parkinson'S Disease|September 24, 2022
Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulationAlessandro Zampogna, Francesco Cavallieri, Francesco Bove, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2015
Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's diseaseRaul Martinez-Fernandez, Pierre Pelissier, Jean-Louis Quesada, et al.
American Journal of Human Genetics|October 13, 2015
A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar AtaxiaMarie Coutelier, Iulia Blesneac, Arnaud Monteil, et al.
Annals of Neurology|December 22, 2020
Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson DiseaseFrancesco Cavallieri, Valérie Fraix, Francesco Bove, et al.
Neurology|May 19, 2019
Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson diseaseGiulia Giannini, Matthieu Francois, Eugénie Lhommée, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2017
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's diseaseBenoit Delpont, Eugénie Lhommée, Hélène Klinger, et al.
Neurology|June 3, 2021
Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson DiseaseFrancesco Bove, Delia Mulas, Francesco Cavallieri, et al.
Brain : a Journal of Neurology|August 20, 2016
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's diseaseAudrey Maillet, Paul Krack, Eugénie Lhommée, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort studyMarie Abbes, Eugénie Lhommée, Stéphane Thobois, et al.
Journal of Parkinson'S Disease|May 9, 2022
Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor SymptomsBruna Meira, Eugénie Lhommée, Emmanuelle Schmitt, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
NPJ Parkinson'S Disease|September 24, 2022
Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulationAlessandro Zampogna, Francesco Cavallieri, Francesco Bove, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 3, 2015
Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's diseaseRaul Martinez-Fernandez, Pierre Pelissier, Jean-Louis Quesada, et al.
American Journal of Human Genetics|October 13, 2015
A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar AtaxiaMarie Coutelier, Iulia Blesneac, Arnaud Monteil, et al.
Annals of Neurology|December 22, 2020
Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson DiseaseFrancesco Cavallieri, Valérie Fraix, Francesco Bove, et al.
Neurology|May 19, 2019
Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson diseaseGiulia Giannini, Matthieu Francois, Eugénie Lhommée, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2017
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's diseaseBenoit Delpont, Eugénie Lhommée, Hélène Klinger, et al.
Neurology|June 3, 2021
Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson DiseaseFrancesco Bove, Delia Mulas, Francesco Cavallieri, et al.
Brain : a Journal of Neurology|August 20, 2016
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's diseaseAudrey Maillet, Paul Krack, Eugénie Lhommée, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort studyMarie Abbes, Eugénie Lhommée, Stéphane Thobois, et al.
Journal of Parkinson'S Disease|May 9, 2022
Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor SymptomsBruna Meira, Eugénie Lhommée, Emmanuelle Schmitt, et al.
Pageof 8